Merck & Co., Inc.
MRK
$115.88
$2.882.55%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 16.29B | 16.40B | 17.28B | 15.81B | 15.53B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.29B | 16.40B | 17.28B | 15.81B | 15.53B |
| Cost of Revenue | 3.88B | 4.30B | 3.75B | 3.39B | 3.38B |
| Gross Profit | 12.41B | 12.11B | 13.53B | 12.41B | 12.15B |
| SG&A Expenses | 2.57B | 2.73B | 2.48B | 2.50B | 2.40B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.00B | 11.03B | 10.23B | 9.88B | 9.31B |
| Operating Income | 6.29B | 5.38B | 7.05B | 5.92B | 6.22B |
| Income Before Tax | -3.53B | 3.42B | 6.75B | 5.00B | 5.90B |
| Income Tax Expenses | 709.00M | 458.00M | 958.00M | 571.00M | 818.00M |
| Earnings from Continuing Operations | -4.24B | 2.96B | 5.79B | 4.43B | 5.09B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 3.00M | 1.00M | -2.00M | -1.00M | -6.00M |
| Net Income | -4.24B | 2.96B | 5.79B | 4.43B | 5.08B |
| EBIT | 6.29B | 5.38B | 7.05B | 5.92B | 6.22B |
| EBITDA | 7.69B | 6.79B | 8.15B | 6.99B | 7.28B |
| EPS Basic | -1.72 | 1.19 | 2.32 | 1.76 | 2.01 |
| Normalized Basic EPS | 1.48 | 1.25 | 1.69 | 1.41 | 1.49 |
| EPS Diluted | -1.72 | 1.19 | 2.32 | 1.76 | 2.01 |
| Normalized Diluted EPS | 1.48 | 1.25 | 1.69 | 1.41 | 1.48 |
| Average Basic Shares Outstanding | 2.47B | 2.49B | 2.50B | 2.51B | 2.52B |
| Average Diluted Shares Outstanding | 2.47B | 2.49B | 2.50B | 2.51B | 2.53B |
| Dividend Per Share | 0.85 | 0.81 | 0.81 | 0.81 | 0.81 |
| Payout Ratio | -49.65% | 68.11% | 35.11% | 46.92% | 40.36% |